Log in to save to my catalogue

Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylatio...

Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylatio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6486348

Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation

About this item

Full title

Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2019-05, Vol.129 (5), p.1984-1999

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Idiopathic pulmonary fibrosis (IPF) is a chronic and deadly disease with a poor prognosis and few treatment options. Pathological remodeling of the extracellular matrix (ECM) by myofibroblasts is a key factor that drives disease pathogenesis, although the underlying mechanisms remain unknown. Alternative polyadenylation (APA) has recently been show...

Alternative Titles

Full title

Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6486348

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6486348

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI122106

How to access this item